계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Nuvaira
company
About
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases.
- 1 - 10
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $79M
- Industries
- Biotechnology,Health Care,Information Technology,Medical Device
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Nuvaira is a new alternative COPD treatment option that specializes in developing devices for treating lung diseases. Nuvaira is currently working on a novel catheter-based system that has the potential to improve lung function, exercise capacity, and quality of life for patients with chronic obstructive pulmonary disease.It was founded in 2008 and headquartered in Minneapolis, Minnesota.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
5
$144.60M
Nuvaira has raised a total of
$144.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 11, 2019 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 11, 2019 | Series E | $79M | 1 | — | — | Detail |
| Apr 3, 2014 | Series D | $42M | 1 | — | — | Detail |
| Feb 8, 2013 | Series C | $10M | 1 | — | — | Detail |
| Sep 20, 2012 | Series B | $10.60M | 1 | — | — | Detail |
| Sep 29, 2010 | Series A | $3M | 1 |
Versant Ventures
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Nuvaira is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Versant Ventures
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
